Carna Biosciences (TSE:4572) Inventories, Finished Goods: 円106.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4572 Carna Biosciences Inc TSE:4572
43 GF Score
Price 円306.00
GF Value 円186.76
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Carna Biosciences Inventories, Finished Goods?

Carna Biosciences TSE:4572 -1.61% 43 Inventories, Finished Goods is 円106.3 Mil as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 43/100 and a GF Value™ of 円186.76 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Carna Biosciences's quarterly finished goods declined from Jun. 2025 (円113.3 Mil) to Sep. 2025 (円109.4 Mil) and declined from Sep. 2025 (円109.4 Mil) to Dec. 2025 (円106.3 Mil).

Carna Biosciences's annual finished goods increased from Dec. 2023 (円94.4 Mil) to Dec. 2024 (円108.1 Mil) but then declined from Dec. 2024 (円108.1 Mil) to Dec. 2025 (円106.3 Mil).

Carna Biosciences Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Inventories, Finished Goods Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.51 84.45 94.38 108.06 106.30

Carna Biosciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.95 113.27 109.39 106.30 105.29
TSE:4572
43GF Score
Carna Biosciences Inc TSE:4572
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of 円106.3 Mil mean?
Carna Biosciences (TSE:4572) has a Inventories, Finished Goods of 円106.3 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Carna Biosciences and its competitors.
Is Carna Biosciences' Inventories, Finished Goods too high?
Carna Biosciences' current Inventories, Finished Goods is 円106.3 Mil. Overall, Carna Biosciences has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Inventories, Finished Goods compare to VRTX and REGN?
Carna Biosciences' Inventories, Finished Goods of 円106.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current Inventories, Finished Goods is 円106.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円186.76, compared to a current price of 円306.00 — trading 63.8% above its estimated fair value. The current Inventories, Finished Goods is 円106.3 Mil. Carna Biosciences' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Inventories, Finished Goods is 円106.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円306.00 is trading 63.8% above its estimated GF Value™ of 円186.76. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Inventories, Finished Goods: 円106.3 Mil
  • GF Value™: 円186.76 vs. price of 円306.00 (63.8% above fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
43GF Score

Get the complete analysis for TSE:4572

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円306.00
Price
円186.76
GF Value